2024 |
Immutep Limited - ADR
|
Executive Director and Chief Scientific Officer |
- |
- |
2023 |
Immutep Limited - ADR
|
Director and Chief Scientific Officer |
- |
- |
2022 |
Immutep Limited - ADR
|
Executive Director, Chief Scientific Officer and Chief Medical Officer |
644.2 K |
-25.0 % |
2021 |
Immutep Limited - ADR
|
Chief Scientific Officer and Chief Medical Officer |
858.6 K |
42.1 % |
2021 |
Immutep Limited - ADR
|
- |
858.6 K |
42.1 % |
2020 |
Immutep Limited - ADR
|
- |
604.4 K |
8.4 % |
2020 |
Immutep Limited - ADR
|
Chief Scientific Officer and Chief Medical Officer |
604.4 K |
8.4 % |
2020 |
Immutep Limited - ADR
|
- |
604.4 K |
8.4 % |
2019 |
Immutep Limited - ADR
|
- |
557.8 K |
-29.1 % |
2019 |
Immutep Limited - ADR
|
Chief Scientific Officer and Chief Medical Officer |
557.8 K |
-29.1 % |
2019 |
Immutep Limited - ADR
|
- |
557.8 K |
-29.1 % |
2018 |
Immutep Limited - ADR
|
- |
786.3 K |
105.9 % |
2018 |
Immutep Limited - ADR
|
- |
786.3 K |
105.9 % |
2018 |
Immutep Limited - ADR
|
Chief Scientific Officer and Chief Medical Officer |
786.3 K |
105.9 % |
2017 |
Immutep Limited - ADR
|
- |
381.8 K |
-37.6 % |
2017 |
Immutep Limited - ADR
|
- |
381.8 K |
-37.6 % |
2017 |
Immutep Limited - ADR
|
Chief Scientific Officer and Chief Medical Officer |
381.8 K |
-37.6 % |
2016 |
Immutep Limited - ADR
|
- |
612.4 K |
370.3 % |
2016 |
Immutep Limited - ADR
|
- |
612.4 K |
370.3 % |
2016 |
Immutep Limited - ADR
|
Chief Scientific Officer and Chief Medical Officer |
612.4 K |
370.3 % |
2015 |
Immutep Limited - ADR
|
- |
130.2 K |
- |
2015 |
Immutep Limited - ADR
|
- |
130.2 K |
- |
2015 |
Immutep Limited - ADR
|
Chief Scientific Officer and Chief Medical Officer |
130.2 K |
- |